How a simple blood test could help detect heart damage during breast cancer treatment

Article excerpt

A simple blood test may soon help doctors detect heart damage during breast cancer treatment, offering a potential shield against one of chemotherapy's most serious side effects. Modern cancer drugs are increasingly effective at prolonging survival, but some targeted therapies and chemotherapy agents can injure the heart muscle, damage that often goes undetected until symptoms emerge. Researchers are exploring whether measuring specific cardiac biomarkers in blood could catch this harm early, before it becomes irreversible. The discovery could change how oncologists monitor patients, allowing them to adjust treatments or intervene sooner when cardiac complications arise.